Global Active Pharmaceutical Ingredients (API) Market - Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Sep 2019
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Active Pharmaceutical Ingredients (API) Market By Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients), Type of Manufacturer (Captive API Manufacturers, Merchant API Manufacturers), Type of Synthesis (Synthetic Active Pharmaceutical Ingredients, Biotech Active Pharmaceutical Ingredients), Type of Drug (Prescription Drugs, Over-The-Counter Drugs), Therapeutic Application (Communicable Diseases, Oncology, Pain Management, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Other Therapeutic Applications), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global Active Pharmaceutical Ingredients (API) Market

Global active pharmaceutical ingredients (API) market is registering a substantial CAGR of 7.17 % in the forecast period of 2019-2026. This rise in the market can be attributed to increased occurrence of chronic diseases, technology advances in API manufacturing and increasing generic significance.

Market Definition: Global Active Pharmaceutical Ingredients (API) Market

Active pharmaceutical ingredient (API) is the component of any drug that generates its effect. Some drugs, such as combination therapy, have various effective components to cure distinct diseases or to behave in distinct respects. Generally, the pharmaceutical companies themselves have produced APIs in their respective nations. But in latest years, many corporations have chosen to ship manufacturing abroad to reduce expenses. This has led to important modifications in the way these drugs are controlled, with more strict guidance and checks in location.

Market Drivers

  • Increased occurrence of chronic diseases is driving the growth of the market
  • Technology advances in API Manufacturing is propelling the growth of the market
  • Increasing generic significance is boosting the growth of the market
  • Increasing implementation of artificial intelligence-based drug discovery instruments is contributing to the growth of the market

Market Restraints

  • Drug costs monitoring strategies throughout countries is hampering the growth of the market
  • Strong rivalry among manufacturers of the API is hindering the growth of the market
  • Growing development of anti-counterfeit drugs is restricting the growth of the market

Segmentation: Global Active Pharmaceutical Ingredients (API) Market

By Type

  • Innovative Active Pharmaceutical Ingredients
  • Generic Active Pharmaceutical Ingredients

By Type of Manufacturer

  • Captive API Manufacturers
  • Merchant API Manufacturers

    • By Type

      • Merchant Innovative API Manufacturers
      • Merchant Generic API Manufacturers

    • By Type of Synthesis

      • Merchant Synthetic API ManufacturersMerchant Biotech API Manufacturers

By Type of Synthesis

  • Synthetic Active Pharmaceutical Ingredients

    • Innovative Synthetic APIS
    • Generic Synthetic APIS

  • Biotech Active Pharmaceutical Ingredients    

    • BY type

      •     Innovative Biotech APIS
      •        Generic Biotech APIS

    • By product

      • Monoclonal Antibodies
      • Hormones & Growth Factors
      • Cytokines
      • Fusion Proteins
      • Recombinant Vaccines
      • Therapeutic Enzymes
      • Blood Factors

    • By Expression System

      • Mammalian Expression Systems
      • Microbial Expression Systems
      • Yeast Expression Systems
      • Insect Expression Systems
      • Other Expression Systems

By Type of Drug

  • Prescription Drugs
  • Over-The-Counter Drugs
  • Potency

    • Low-To-Moderate Potency Active Pharmaceutical Ingredients
    • Potent-To-Highly Potent Active Pharmaceutical Ingredient

By Therapeutic Application

  • Communicable Diseases
  • Oncology
  • Pain Management
  • Cardiovascular Diseases
  • Diabetes
  • Respiratory Diseases
  • Other Therapeutic Application

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East & Africa

 Key Developments in the Market:

  • In October 2018, The Serdex Company, which is a subsidiary of Seppic, has been created to manufacture the primary component of this drug, TECA Pharma. SEPPIC, following its recent acquirement of Serdex, is now supplying its customers with this API with TECA Pharma Good Production Procedures certification and an Active Substance Master File to assist with statutory handling.
  • In September 2018, Lonza Pharma & Biotech announced the start of its quickly-intermediate pharmaceutical production project. The project optimizes chemical production installations at the company's Visp (CH) facility to tackle growing worldwide early-stage supply safety and performance issues. Lonza is offering its clients an embedded supply chain from non-GMP late intermediates to CGMP sophisticated intermediates and APIs.

Competitive Analysis:

Global active pharmaceutical ingredients (API) market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of active pharmaceutical ingredients (API) market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in the global active pharmaceutical ingredients (API) market are Pfizer Inc., Novartis AG, Sanofi, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company., GlaxoSmithKline plc., Merck Sharp & Dohme Corp., AbbVie Inc., AstraZeneca, Aurobindo Pharma, BASF SE, Dr. Reddy’s Laboratories Ltd., LUPIN., Mylan N.V., Sun Pharmaceutical Industries Ltd, Piramal Pharma Solutions, Sandoz International GmbH, Saneca Pharmaceuticals a. s and others.

Research Methodology:  Global Active Pharmaceutical Ingredients (API) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global active pharmaceutical ingredients (API) market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19